This federal contract award, with ID SPE2DB22D3501|SPE2DB25FTK91, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $9,165.54 firm fixed-price delivery order is for the pharmaceutical product COSENTYX SNRDY 300MG DOSE-2PENML, with a completion date of November 8, 2024.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that maintains an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies.
The contract award does not have a set-aside designation, indicating open competition. No subcontractor information is provided.
Generated 2/6/25, 9:15 AM